You will be the leader of the QA Automation department.Team mentoring in a Agile organization.Define and execute test using different techniques and tools.Planning, allocation and control testing activities of the project.Review results of ...
here. What you will do As a Brand Activation intern, the candidate will participate in the execution of the integrated marketing plan for pharma...-solving skill and critical thinking Interest in pharma sector. What's in it for you Learning & Development Opportunities...
candidate will participate in the execution of the integrated marketing plan for pharma Selfcare brands in the Spanish market... and proactiveness Autonomous profile with a good problem-solving skill and critical thinking Interest in pharma sector. What's in...
Title: Medical and Regulatory Affairs Director Iberia Company: Ipsen Pharma SA Job Description: At Ipsen..., franchises, IPSEN Community Medical and R & D To supervise the clinical studies performed by IPSEN-PHARMA. To ensure medical...
UltraTech Cement, Adani Group (Ambuja Cements, ACC), Shree Cement, Dalmia Bharat, Nuvoco Vista: ICRA sees top 5 cement companies market share climbing to 55% by March 2025. Continue Reading »
Axis recommends constructing a diversified portfolio spanning multiple asset classes to safeguard against market volatility. The brokerage is overweight on equities, neutral on fixed-income assets and gold. Market dynamics will pivot around prevailing narratives, influencing investment decisions. Continue Reading »
Dabur shares have been Emkay Global’s preferred consumption pick given its relatively higher share of rural, diversified portfolios and its sustained thrust on NPDs. The brokerage firm has raised Dabur share price target to ₹700 per share from ₹660 earlier, and has a ‘Buy’ rating on the stock. Continue Reading »
Durlax Top Surface IPO GMP: Durlax Top Surface Limited Shares are available at a premium of ₹15 in the grey market today, say market observers. Continue Reading »
Akme Fintrade IPO GMP is at ₹33 per share, indicating a premium of 27.5% over the IPO price of ₹120. The IPO is set to launch next week with a price band of ₹114-120 per share. Continue Reading »
MTAR poised for growth with long-term agreement with IAI for aviation sector worth US$90-120 million. Renewable energy faces grid stability issues. Fuel cells and nuclear energy emerge as viable alternatives, benefiting MTAR significantly. InCred Equities forecasts 42% upside in MTAR stock. Continue Reading »